Showing results (141-150 of 209) with videos related to
Sort By:
Pageof 21
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementationMarianela Candolfi, Kurt M Kroeger, Weidong Xiong, et al.Molecular Cancer Therapeutics|May 13, 2020
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces AstrogliosisLanxin Luo, Xiudong Guan, Gulnaz Begum, et al.Lab on a Chip|February 28, 2019
A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic nicheC Ryan Oliver, Megan A Altemus, Trisha M Westerhof, et al.Nature Reviews. Neurology|April 24, 2013
Progress in gene therapy for neurological disordersMichele Simonato, Jean Bennett, Nicholas M Boulis, et al.The Journal of Experimental Medicine|August 23, 2006
In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brainCarlos Barcia, Clare E Thomas, James F Curtin, et al.STAR Protocols|March 17, 2023
Generation of 3D ex vivo mouse- and patient-derived glioma explant slice model for integration of confocal time-lapse imaging and spatial analysisAndrea Comba, Maria Luisa Varela, Syed M Faisal, et al.Cancer Research|August 17, 2005
Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma modelSumia Ali, Gwendalyn D King, James F Curtin, et al.Human Gene Therapy Methods|September 7, 2012
Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialA K M Ghulam Muhammad, Weidong Xiong, Mariana Puntel, et al.Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
Oncogenic IDH1mut drives robust loss of histone acetylation and increases chromatin heterogeneityNoa Furth, Niv Cohen, Avishay Spitzer, et al.Journal of Cancer Research and Clinical Oncology|April 23, 2017
Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancerMariela A Moreno Ayala, María Florencia Gottardo, María Soledad Gori, et al.Pageof 21